Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Nature Protocols
|
May 29, 2015
Erratum: RGB marking with lentiviral vectors for multicolor clonal cell tracking
Kristoffer Weber, Michael Thomaschewski, Daniel Benten, et al.
Nature Protocols
|
April 7, 2012
RGB marking with lentiviral vectors for multicolor clonal cell tracking
Kristoffer Weber, Michael Thomaschewski, Daniel Benten, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 26, 2008
A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis
Kristoffer Weber, Udo Bartsch, Carol Stocking, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
June 24, 2011
Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect
Ellen Preuss, Alexander Muik, Kristoffer Weber, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
July 3, 2010
Highly efficient lentiviral transduction of phenotypically and genotypically characterized endothelial progenitor cells from adult peripheral blood
Marcus Stockschlaeder, Olga Shardakova, Kristoffer Weber, et al.
Blood
|
March 11, 2008
The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate
Andrea Schüler, Maike Schwieger, Afra Engelmann, et al.
Stem Cells (Dayton, Ohio)
|
March 18, 2010
Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation
Vida Vafaizadeh, Petra Klemmt, Christian Brendel, et al.
Cancer Research
|
January 17, 2009
Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3
Martin Michaelis, Florian Rothweiler, Denise Klassert, et al.
Plos One
|
August 29, 2012
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies
Michael Preukschas, Christian Hagel, Alexander Schulte, et al.
Human Gene Therapy
|
March 6, 2010
TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy
Ellen Preuss, Alexandra Treschow, Sebastian Newrzela, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Nature Protocols
|
May 29, 2015
Erratum: RGB marking with lentiviral vectors for multicolor clonal cell tracking
Kristoffer Weber, Michael Thomaschewski, Daniel Benten, et al.
Nature Protocols
|
April 7, 2012
RGB marking with lentiviral vectors for multicolor clonal cell tracking
Kristoffer Weber, Michael Thomaschewski, Daniel Benten, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 26, 2008
A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis
Kristoffer Weber, Udo Bartsch, Carol Stocking, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
June 24, 2011
Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect
Ellen Preuss, Alexander Muik, Kristoffer Weber, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
July 3, 2010
Highly efficient lentiviral transduction of phenotypically and genotypically characterized endothelial progenitor cells from adult peripheral blood
Marcus Stockschlaeder, Olga Shardakova, Kristoffer Weber, et al.
Blood
|
March 11, 2008
The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate
Andrea Schüler, Maike Schwieger, Afra Engelmann, et al.
Stem Cells (Dayton, Ohio)
|
March 18, 2010
Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation
Vida Vafaizadeh, Petra Klemmt, Christian Brendel, et al.
Cancer Research
|
January 17, 2009
Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3
Martin Michaelis, Florian Rothweiler, Denise Klassert, et al.
Plos One
|
August 29, 2012
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies
Michael Preukschas, Christian Hagel, Alexander Schulte, et al.
Human Gene Therapy
|
March 6, 2010
TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy
Ellen Preuss, Alexandra Treschow, Sebastian Newrzela, et al.
Page
of 2